Impaired blood-brain barrier function in angiotensinogen-deficient mice

被引:121
作者
Kakinuma, Y
Hama, H
Sugiyama, F
Yagami, K
Goto, K
Murakami, K
Fukamizu, A [1 ]
机构
[1] Univ Tsukuba, Inst Appl Biochem, Tsukuba, Ibaraki 305, Japan
[2] Univ Tsukuba, Inst Basic Med Sci, Dept Pharmacol, Tsukuba, Ibaraki 305, Japan
[3] Univ Tsukuba, Lab Anim Res Ctr, Tsukuba, Ibaraki 305, Japan
[4] Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 305, Japan
[5] Natl Inst Adv Interdisciplinary Res, Tsukuba, Ibaraki 3058572, Japan
关键词
D O I
10.1038/2070
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Astrocytes in the central nervous system have physiologically important roles in the response to brain injury(1,2). Brain damage results in disruption of the blood-brain barrier (BBB), producing detachment of astrocyte endfeet from endothelial cells(3). The resultant leakage of serum proteins from loosened tight junctions between endothelial cells produces brain edema. At the same time, reactive astrocytes migrate to the injured area, where they proliferate and produce extracellular matrix(4-6), thereby reconstituting the BBB. As astrocytes are known to express angiotensinogen(7,8), which is the precursor of angiotensins (Al to AIV), we have investigated a possible functional contribution of angiotensinogen or one of its metabolites to BBB reconstitution. The astrocytes of angiotensinogen knockout mice had very attenuated expression of glial fibrially acidic protein and decreased laminin production in response to cold injury, and ultimately incomplete reconstitution of impaired BBB function. Although these abnormalities were rescued by administration of All or AIV, the restoration of BBB function was not inhibited by All type 1 and 2 receptor antagonists. These findings provide evidence that astrocytes with angiotensins are required for functional maintenance of the BBB.
引用
收藏
页码:1078 / 1080
页数:3
相关论文
共 26 条
  • [11] GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination
    Liedtke, W
    Edelmann, W
    Bieri, PL
    Chiu, FC
    Cowan, NJ
    Kucherlapati, R
    Raine, CS
    [J]. NEURON, 1996, 17 (04) : 607 - 615
  • [12] LUDWIN SK, 1985, LAB INVEST, V52, P20
  • [13] MILLERWING AV, 1993, J PHARMACOL EXP THER, V266, P1718
  • [14] ASTROCYTE CULTURES DERIVED FROM HUMAN BRAIN-TISSUE EXPRESS ANGIOTENSINOGEN MESSENGER-RNA
    MILSTED, A
    BARNA, BP
    RANSOHOFF, RM
    BROSNIHAN, KB
    FERRARIO, CM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (15) : 5720 - 5723
  • [15] Distribution of AT(4) receptors in the Macaca fascicularis brain
    Moeller, I
    Paxinos, G
    Mendelsohn, FAO
    Aldred, GP
    Casley, D
    Chai, SY
    [J]. BRAIN RESEARCH, 1996, 712 (02) : 307 - 324
  • [16] THE CONTROL OF GLIAL POPULATIONS IN BRAIN - CHANGES IN ASTROCYTE MITOGENIC AND MORPHOGENIC FACTORS IN RESPONSE TO INJURY
    NIETOSAMPEDRO, M
    SANETO, RP
    DEVELLIS, J
    COTMAN, CW
    [J]. BRAIN RESEARCH, 1985, 343 (02) : 320 - 328
  • [17] ASTROCYTE RESPONSES TO CNS INJURY
    NORENBERG, MD
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1994, 53 (03) : 213 - 220
  • [18] REIER PJ, 1986, CELL BIOL PATHOLOGY, P263
  • [19] AUTORADIOGRAPHIC IDENTIFICATION OF BRAIN ANGIOTENSIN-IV BINDING-SITES AND DIFFERENTIAL C-FOS EXPRESSION FOLLOWING INTRACEREBROVENTRICULAR INJECTION OF ANGIOTENSIN-II AND ANGIOTENSIN-IV IN RATS
    ROBERTS, KA
    KREBS, LT
    KRAMAR, EA
    SHAFFER, MJ
    HARDING, JW
    WRIGHT, JW
    [J]. BRAIN RESEARCH, 1995, 682 (1-2) : 13 - 21
  • [20] SHIBOUTA Y, 1993, J PHARMACOL EXP THER, V266, P114